BrightGene Bio-Medical Technology Co., Ltd.

Chinese drugmaker of APIs, generic formulations, and weight-loss drug candidates

What BrightGene Bio-Medical does

BrightGene is a Suzhou-based pharmaceutical company that researches, makes, and sells medicines in China and abroad. It supplies active drug ingredients, intermediates, finished drugs, and veterinary drugs across many therapy areas, from oncology and anti-infectives to cardiovascular disease. It is also developing new drugs for diabetes and obesity, led by BGM0504, which is in Phase III trials.

How BrightGene Bio-Medical makes money

Most revenue comes from selling active pharmaceutical ingredients, intermediates, and finished formulations to drugmakers and markets in China and abroad. Technology transfer, technical services, and trading in medicines add more income, while its pipeline of metabolic drugs could bring in money in the future.

Products & services

• BGM0504 injection (Phase III, type 2 diabetes and weight loss)
• BGM1812 long-acting amylin analog (preclinical)
• Active pharmaceutical ingredients and intermediates
• Finished drug formulations
• Veterinary drugs
• Technology transfer and technical services